Live Breaking News & Updates on Silence Therapeutic

Stay updated with breaking news from Silence therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insiders the biggest winners as Silence Therapeutics plc's (NASDAQ:SLN) market cap rises to US$736m

Key Insights Significant insider control over Silence Therapeutics implies vested interests in company growth 53% of. ....

Richard Griffiths , Robert Keith , Lombard Odier Asset Management United States Corp , Silence Therapeutic , Silence Therapeutics , Lombard Odier Asset Management , United States , Nstitutional Ownership , Nsider Ownership ,

Silence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenues

Silence Therapeutics plc ( NASDAQ:SLN ) shares have had a really impressive month, gaining 65% after a shaky period. ....

How Silence Therapeutics Has Been , Silence Therapeutics , Silence Therapeutic , Revenue Growth , Share Price ,

Head-To-Head Review: IntelGenx Technologies (OTCMKTS:IGXT) vs. Silence Therapeutics (NASDAQ:SLN)

IntelGenx Technologies (OTCMKTS:IGXT – Get Free Report) and Silence Therapeutics (NASDAQ:SLN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation. Valuation & Earnings This table compares IntelGenx […] ....

United Kingdom , City Of , Mallinckrodt Pharma , Hansoh Pharmaceutical Group Company , Cynapsus Therapeutics Inc , Intelgenx Technologies Corp , Tilray Inc , Intelgenx Technologies , Get Free Report , Silence Therapeutics , Silence Therapeutic , Genx Technologies , Given Silence Therapeutic , Genx Technologies Corp , Cynapsus Therapeutics , Oligonucleotide Discovery , Hansoh Pharmaceutical Group Company Limited , Intelgenx Technologies Daily , Otcmkts Igxt , Stock Comparison , Stock Analysis ,

Silence Therapeutics plc Forecasted to Post Q1 2024 Earnings of ($0.46) Per Share (NASDAQ:SLN)

Silence Therapeutics plc (NASDAQ:SLN – Free Report) – Analysts at William Blair issued their Q1 2024 EPS estimates for Silence Therapeutics in a report released on Thursday, August 3rd. William Blair analyst M. Minter forecasts that the company will post earnings of ($0.46) per share for the quarter. The consensus estimate for Silence Therapeutics’ current […] ....

William Blair , Citadel Advisors , Morgan Stanley , Schonfeld Strategic Advisors , Millennium Management , Silence Therapeutics , Free Report , Silence Therapeutic , Get Free Report , Strategic Advisors , Oligonucleotide Discovery , Silence Therapeutics Daily , Nasdaq Sln , Earnings Estimates ,

Silence Therapeutics plc (NASDAQ:SLN) to Post FY2025 Earnings of ($2.04) Per Share, William Blair Forecasts

Silence Therapeutics plc (NASDAQ:SLN – Get Rating) – Equities researchers at William Blair issued their FY2025 earnings per share estimates for shares of Silence Therapeutics in a research note issued on Tuesday, March 28th. William Blair analyst M. Minter expects that the company will earn ($2.04) per share for the year. The consensus estimate for […] ....

Robertw Baird , William Blair , Schonfeld Strategic Advisors , Citadel Advisors , Millennium Management , Morgan Stanley , Silence Therapeutics Company Profile , Silence Therapeutics , Get Rating , Silence Therapeutic , Strategic Advisors , Oligonucleotide Discovery , Silence Therapeutics Daily , Nasdaq Sln , Earnings Estimates ,